ASIC released their latest insolvency statistics earlier this week and the results are concerning. A company becomes ...

By Christine Chen (Reuters) -Australian biopharmaceutical company CSL posted higher first-half profits as growth in its main blood-plasma business helped offset weaker flu vaccine sales, which were ...

Corporate Australia kicks off its half-year earnings in full swing next week, and while modest growth is expected, traders ...